Blood Transfusion vs. Plasma Transfusion: Components, Indications & Key Differences

Modern transfusion medicine practices component therapy—separating whole blood into specific products to treat specific deficits, minimizing unnecessary exposure and optimizing inventory.

Blood Transfusion (Component Therapy)

  • Red Blood Cells (RBCs): For symptomatic anemia (Hb <7–8 g/dL) or acute blood loss. Restores oxygen-carrying capacity.
  • Platelets: For thrombocytopenia (<10–20×10⁹/L) or platelet dysfunction with bleeding/invasive procedure.
  • Fresh Frozen Plasma (FFP): For multiple coagulation factor deficiencies (INR >1.5–2.0), warfarin reversal, TTP (plasma exchange preferred), massive transfusion.
  • Cryoprecipitate: Concentrated fibrinogen, Factor VIII, vWF. For fibrinogen <100–150 mg/dL, von Willebrand disease.

Plasma Transfusion (FFP)

Plasma is the liquid component (~55% blood volume) containing clotting factors, albumin, immunoglobulins, electrolytes. Indications:

  • Bleeding with coagulopathy (INR >1.5–2.0) before invasive procedures.
  • Massive transfusion protocol (1:1:1 RBC:FFP:Platelets).
  • TTP — therapeutic plasma exchange (TPE) is standard; FFP if TPE unavailable.
  • Specific factor deficiency when concentrate unavailable.

Key Differences

AspectRBC/Platelet TransfusionPlasma (FFP) Transfusion
Primary PurposeO₂ delivery (RBC) / hemostasis (platelets)Replace clotting factors, volume expansion
Volume per Unit~250–350 mL (RBC); ~50–70 mL (platelets)~200–250 mL
ABO CompatibilityCritical for RBCs; less strict for plateletsMust be ABO-compatible (avoid anti-A/B in donor plasma)
StorageRBCs: 42 days at 4°C; Platelets: 5–7 days at 22°C with agitationFrozen ≤-18°C up to 1 year; thawed 24h at 4°C
Key RisksTransfusion reactions, infection, iron overload (RBCs)TRALI, TACO, allergic reactions, volume overload

Transfusion decisions integrate clinical context, lab values, and patient factors. Component therapy is the standard of care.

Blood Disorders - Related Articles